Offering a truly value-based healthcare platform.
Our FUSION Platform provides a market ready, software as a medical service (SaMS) offering a truly personalized, predictive, precision patient centric platform that can significantly enhance the efficiency of Medtech and BioPharma and digital therapeutics (DTx) products applicable to any therapeutic area.
Our Cloud integration approach uses a system of tools and technologies to connect various applications, systems, repositories, and IT environments for the real-time exchange of data and processes.
Our open platform architecture
Our FUSIONTM platform is a platform & device-agnostic solution that can easily support multiple products and services.
Data Security & Privacy
Privacy compliance support, including audit logs, data retention, incident response and breach notifications, Data Protection Impact Assessment, and patient consent management.
Multiple Dashboard Experience
FUSIONTM generates real-time insights from real-world drug development, medical device and DTx data.
Our Dashboards provide analytics to enable patient communication, to enhance DTx. Drug and device utilization data to support real-world evidence of drug adherence. Our multiple and fully customisable dashboard offers a great user experience as you can easily create and receive the data you want.
Unprecedented User Experience. Impeccable Data Exchange.
Our Multi-functional team of experts
and our robust technology platform is
trusted by regulatory bodies, pharma and drug-device manufacturers, partner therapy platforms, clinicians and patients to power their global digital therapeutic initiatives across their life cycle.
Our FUSIONTM platform combines multiple stakeholders to optimise digital therapeutics (DTx) empowering people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes.
Our FUSION ML Platform provides a market ready, software as a medical service (SaMS) offering a truly personalized, predictive, precision patient centric platform that can significantly enhance the efficiency of Medtech and BioPharma and digital therapeutics (DTx) products applicable to any therapeutic area.